Ali MU, Rahman U, Jia MS, Z., Jiang C (2017) Eukaryotic translation initiation factors and cancer. Tumor Biol 39(6):101042831770980. https://doi.org/10.1177/1010428317709805

Article  CAS  Google Scholar 

Bhoori S, Mazzaferro V (2020) Combined immunotherapy and VEGF-antagonist in hepatocellular carcinoma: a step forward. Lancet Oncol 21(6):740–741. https://doi.org/10.1016/S1470-2045(20)30211-4

Article  PubMed  Google Scholar 

Chae M, Lee JH, Park JH, Keum DY, Jung H, Lee Y, Lee DH (2024) Different role of TRF1 and TRF2 expression in non-small cell lung cancers. OncoTargets Ther 17:463–469. https://doi.org/10.2147/OTT.S461430

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chan ACY, Chan SC, Chok KSH, Cheung TT, Chiu DW, Poon RTP, Fan ST, Lo CM (2013) Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Transpl 19(4):411–419. https://doi.org/10.1002/lt.23605

Article  PubMed  Google Scholar 

Chen Q, Yang B, Nass N, Schatz C, Haybaeck J (2020) Impact of eukaryotic translation initiation factors on breast cancer: still much to investigate. Cancers. https://doi.org/10.3390/cancers12071984

Article  PubMed  PubMed Central  Google Scholar 

Chukka PAR, Wetmore SD, Thakor N (2021) Established and emerging regulatory roles of eukaryotic translation initiation factor 5B (eIF5B). Front Genet. https://doi.org/10.3389/fgene.2021.737433

Article  PubMed  PubMed Central  Google Scholar 

de la Parra C, Walters BA, Geter P, Schneider RJ (2018) Translation initiation factors and their relevance in cancer. Curr Opin Genet Dev 48:82–88. https://doi.org/10.1016/j.gde.2017.11.001

Article  PubMed  CAS  Google Scholar 

Dixit S, Sadanandam A (2021) The 2nd conference and workshop of the cancer genome atlas (TCGA) in india: towards team science for Multi-omics cancer research in South Asia. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2021.ed111

Article  PubMed  PubMed Central  Google Scholar 

Fei D, Wang F, Wang Y, Chen J, Chen S, Fan L, Yang L, Ren Q, Duangmano S, Du F, Liu H, Zhou J, Sheng J, Zhao Y, Wu X, Li M, Xiao Z, Zhang Z, Jiang X (2024) Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway. Mol Cancer 23(1):159. https://doi.org/10.1186/s12943-024-02074-z

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hao P, Yu J, Ward R, Liu Y, Hao Q, An S, Xu T (2020) Eukaryotic translation initiation factors as promising targets in cancer therapy. Cell Commun Signal 18(1):175. https://doi.org/10.1186/s12964-020-00607-9

Article  CAS  Google Scholar 

Huang B, Yang K (2023) Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer. Genes Genomics 45(9):1197–1209. https://doi.org/10.1007/s13258-023-01410-9 [Erratum in: Genes Genomics. 2023. https://doi.org/10.1007/s13258-023-01425-2]

Jeong EA, Lee MH, Bae AN, Kim J, Park JH, Lee JH (2024) A comprehensive analysis of HOXB13 expression in hepatocellular carcinoma. Medicina. https://doi.org/10.3390/medicina60050716

Article  PubMed  PubMed Central  Google Scholar 

Kim HR, Kim J (2023) Value of TMEM115 as a potential prognostic biomarker in liver hepatocellular carcinoma. Keimyung Med J 42(2):87–96

Article  Google Scholar 

Kim HR, Seo CW, Lee JH, Han SJ, Kim J (2022) SAMD13 as a novel prognostic biomarker and its correlation with infiltrating immune cells in hepatocellular carcinoma. Biomed Sci Lett 28(4):260–275. https://doi.org/10.15616/BSL.2022.28.4.260

Article  Google Scholar 

Li Q, Xiao M, Shi Y, Hu J, Bi T, Wang C, Yan L, Li X (2021) eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1. BMC Cancer 21(1):1022. https://doi.org/10.1186/s12885-021-08749-w

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li X, Wang Q, Liang H, Chen S, Chen H, Lu Y, Yang C (2022) IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells. Oncol Res 30(2):77–87. https://doi.org/10.32604/or.2022.026511

Article  PubMed  CAS  Google Scholar 

Liu CY, Chen KF, Chen PJ (2015) Treatment of liver cancer. Cold Spring Harbor Perspect Med 5(9):a021535. https://doi.org/10.1101/cshperspect.a021535

Article  CAS  Google Scholar 

Luzha J, Nass N, Czapiewski P, Schroeder N, Kalinski T, Schostak M, Schatz C, Jandrig B, Haybaeck J (2023) Expression of eukaryotic translation initiation factors in the urothelial carcinoma of the bladder. Anticancer Res 43(4):1437–1448. https://doi.org/10.21873/anticanres.16292

Article  PubMed  CAS  Google Scholar 

Marengo A, Rosso C, Bugianesi E (2016) Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med 67(1):103–117. https://doi.org/10.1146/annurev-med-090514-013832

Article  PubMed  CAS  Google Scholar 

McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(S1):4–13. https://doi.org/10.1002/hep.31288

Article  PubMed  CAS  Google Scholar 

Moghimi A, Bani Hosseinian N, Mahdipour M, Ahmadpour E, Miranda-Bedate A, Ghorbian S (2024) Deciphering the molecular complexity of hepatocellular carcinoma: unveiling novel biomarkers and therapeutic targets through advanced bioinformatics analysis. Cancer Rep. https://doi.org/10.1002/cnr2.2152

Article  Google Scholar 

Mohapatra P, Chandrasekaran N (2022) Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: a review. Biomed Pharmacother 155:113713. https://doi.org/10.1016/j.biopha.2022.113713

Article  PubMed  CAS  Google Scholar 

Ross JA, Dungen K, Vanden, Bressler KR, Fredriksen M, Sharma K, Balasingam D, N., Thakor N (2019) Eukaryotic initiation factor 5B (eIF5B) provides a critical cell survival switch to glioblastoma cells via regulation of apoptosis. Cell Death Dis 10(2):57. https://doi.org/10.1038/s41419-018-1283-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ross JA, Ahn BY, King J, Bressler KR, Senger DL, Thakor N (2020) Eukaryotic initiation factor 5B (eIF5B) regulates temozolomide-mediated apoptosis in brain tumour stem cells (BTSCs). Biochem Cell Biol 98(6):647–652. https://doi.org/10.1139/bcb-2019-0329

Article  PubMed  CAS  Google Scholar 

Rubio A, Garland GD, Sfakianos A, Harvey RF, Willis AE (2022) Aberrant protein synthesis and cancer development: the role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis. Sem Cancer Biol 86:151–165. https://doi.org/10.1016/j.semcancer.2022.04.006

Article  CAS  Google Scholar 

Shi L, Shang X, Nie K, Lin Z, Zheng M, Wang M, Yuan H, Zhu Z (2021) Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma. J Clin Pathol 74(8):504–512. https://doi.org/10.1136/jclinpath-2020-206979

Article  PubMed  CAS  Google Scholar 

Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, Hochman T, Formenti SC, Schneider RJ (2009) Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol 11(7):903–908. https://doi.org/10.1038/ncb1900

Article  PubMed  CAS  Google Scholar 

Smith RCL, Kanellos G, Vlahov N, Alexandrou C, Willis AE, Knight JRP, Sansom OJ (2021) Translation initiation in cancer at a glance. J Cell Sci. https://doi.org/10.1242/jcs.248476

Article  PubMed  PubMed Central  Google Scholar 

Song S, Pan J, Zhang Y, Xu Y, Zhang Q, Xie X, Zhou Q, Mo F, Luo G, Chao N (2023) P14.5 functions to inhibit cell migration and can be usedas a prognostic marker in hepatocellular carcinoma. Genes Genomics 45(1):83–91

Article  PubMed  CAS  Google Scholar 

Spilka R, Ernst C, Mehta AK, Haybaeck J (2013) Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett 340(1):9–21. https://doi.org/10.1016/j.canlet.2013.06.019